Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Oatridge, A. Articles by Bydder, G. M. Search for Related Content PubMed PubMed Citation Articles by Oatridge, A. Articles by Bydder, G. M.

American Journal of Neuroradiology 23:1539-1544, October 2002
© 2002 American Society of Neuroradiology

BRAIN

Changes in Brain Size with Treatment in Patients with Hyper- or Hypothyroidism

Angela Oatridge^a, Maria L. Barnard^b, Basant K. Puri^a, Simon D. Taylor-Robinson^a, Joseph V. Hajnal^a, Nadeem Saeed^a and Graeme M. Bydder^a

^a Robert Steiner Magnetic Resonance Unit, Imaging Sciences Department, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London, England
^b Department of Endocrinology, the Whittington Hospital, Highgate Hill, London, England

Address reprint requests to Graeme M. Bydder, Robert Steiner Magnetic Resonance Unit, Imaging Sciences Department, Faculty of Medicine London, Imperial College, Hammersmith Hospital Campus, London, W12 OHS, England

BACKGROUND AND PURPOSE: Although neuropsychological symptoms and signs are common in thyroid disease, their organic substrate is unknown. We performed brain MR imaging in patients with hyperthyroidism or hypothyroidism before and after treatment and correlated the results with hormonal markers.

METHODS. Eight patients with hyperthyroid disease and three with hypothyroid disease underwent imaging within 1–2 days of a thyroid hormone testing. Images were registered, and brain and ventricular sizes were measured by using a semiautomated contour and thresholding technique. Changes in brain and ventricular volume were correlated with serum levels of total thyroxine (T₄), unbound triiodothyronine (free T₃), and thyroid-stimulating hormone (TSH) before and after treatment.

RESULTS. With treatment, brain size decreased by 6,329–31,183 mm³ in the hyperthyroid group and increased by 2,599–48,825 mm³ in the hypothyroid group. Conversely, with treatment, ventricular size increased by 325–6,279 mm³ in the hyperthyroid group and decreased by 760–2,376 mm³ in the hypothyroid group. There was a highly significant correlation between reduction in brain size and reduction in T₄, as well as between the increase in ventricular size and reduction in T₄. There was a significant correlation between reduction in ventricular size and reduction in free T₃. There were highly significant correlations between reduced levels of TSH and increase in brain size, as well as between increased levels of TSH and increase in ventricular size.

CONCLUSION. In thyroid disease, the size of the brain and ventricles significantly change after treatment, and these changes are correlated with T₄, free T₃, and TSH levels. The mechanism of these changes is uncertain, but it may involve osmolyte regulation, the sodium and water balance, and alterations in cerebral hemodynamics.

This article has been cited by other articles:

				Y. Krausz, N. Freedman, H. Lester, J.P. Newman, G. Barkai, M. Bocher, R. Chisin, and O. Bonne Regional Cerebral Blood Flow in Patients with Mild Hypothyroidism J. Nucl. Med., October 1, 2004; 45(10): 1712 - 1715. [Abstract] [Full Text] [PDF]